Cargando…

Contemporary Therapies and Future Directions in the Management of Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is a genetic disorder caused by pathogenic variants in sarcomeric genes, leading to left ventricular hypertrophy and complex phenotypic heterogeneity. While HCM is the most common inherited cardiomyopathy, pharmacological treatment options have previously been limit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Packard, Elizabeth, de Feria, Alejandro, Peshin, Supriya, Reza, Nosheen, Owens, Anjali Tiku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652179/ https://www.ncbi.nlm.nih.gov/pubmed/36243823 http://dx.doi.org/10.1007/s40119-022-00283-5

Ejemplares similares

Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy in Adult Solid Organ Transplant Recipients
por: Reza, Nosheen, et al.
Publicado: (2021)

Familial Hypertrophic Cardiomyopathy: Diagnosis and Management
por: Litt, Michael J, et al.
Publicado: (2023)

Cardiovascular Characteristics of Patients with Genetic Variation in Desmoplakin (DSP)
por: Reza, Nosheen, et al.
Publicado: (2022)

Contemporary Diagnosis and Management of Hypertrophic Cardiomyopathy: The Role of Echocardiography and Multimodality Imaging
por: Kitai, Takeshi, et al.
Publicado: (2022)

Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy and Future Directions
por: Dong, Tiffany, et al.
Publicado: (2023)

Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity
por: de Feria, Alejandro E, et al.
Publicado: (2021)

Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy
por: Thompson, Elizabeth W., et al.
Publicado: (2021)

Antepartum Diagnosis and Management of Lamin A/C Disease
por: Reza, Nosheen, et al.
Publicado: (2019)

Stable Rates of Obstructive Hypertrophic Cardiomyopathy in a Contemporary Era
por: Butzner, Michael, et al.
Publicado: (2022)

Applying Shared Decision Making to Sports Participation for a Patient With Hypertrophic Cardiomyopathy
por: de Feria, Alejandro E., et al.
Publicado: (2020)

Cardiac Amyloidosis Masked as Hypertrophic Cardiomyopathy: A Case Report
por: Wang, Jing, et al.
Publicado: (2016)

Sleep Disordered Breathing in Hypertrophic Cardiomyopathy—Current State and Future Directions
por: Venkataraman, Shreyas, et al.
Publicado: (2020)

A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy
por: Iacovoni, Attilio, et al.
Publicado: (2012)

Risk assessment in hypertrophic cardiomyopathy: contemporary guidelines hampered by insufficient evidence
por: McKeown, Pascal P, et al.
Publicado: (2013)

Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonance( )
por: Huurman, Roy, et al.
Publicado: (2022)

Hypertrophic Cardiomyopathy—Past, Present and Future
por: Liew, Alphonsus C., et al.
Publicado: (2017)

Future bradyarrhythmia in patients with hypertrophic cardiomyopathy
por: Nakasuka, Kosuke, et al.
Publicado: (2021)

Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2019)

Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective
por: Gragnano, Felice, et al.
Publicado: (2023)

Hypertrophic Cardiomyopathy: A Cardiovascular Challenge Becoming a Contemporary Treatable Disease
por: Sakellaropoulos, Stefanos G., et al.
Publicado: (2023)

Diagnosis and management of hypertrophic cardiomyopathy
por: Pantazis, Antonis, et al.
Publicado: (2015)

Disopyramide for Hypertrophic Cardiomyopathy
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2019)

Hypertrophic Cardiomyopathy—Current Challenges and Future Perspectives
por: Monda, Emanuele, et al.
Publicado: (2023)

Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing?
por: Mazzarotto, Francesco, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy: An Overview of Genetics and Management
por: Teekakirikul, Polakit, et al.
Publicado: (2019)

The role of echocardiography in management of hypertrophic cardiomyopathy
por: Haland, Trine F., et al.
Publicado: (2019)

Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies
por: Kawana, Masataka, et al.
Publicado: (2022)

Stage-specific therapy for hypertrophic cardiomyopathy
por: Argirò, Alessia, et al.
Publicado: (2023)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Anesthetic management of a patient with apical hypertrophic cardiomyopathy, a not so rare variant of hypertrophic cardiomyopathy
por: Ramachandran, Srinivasan, et al.
Publicado: (2023)

Management of hypertrophic obstructive cardiomyopathy in prone position
por: Gosavi, Kundan S, et al.
Publicado: (2012)

Management of a Rare Variant of Hypertrophic Cardiomyopathy
por: Khalid, Sidra, et al.
Publicado: (2018)

Alternative Management Options for Hypertrophic Cardiomyopathy: Feasible?
por: Raimondo, Cristina, et al.
Publicado: (2020)

Advance Care Planning: Contemporary Issues and Future Directions
por: Carr, Deborah, et al.
Publicado: (2017)

Management of Type 2 Diabetes in Stage C Heart Failure with Reduced Ejection Fraction
por: Agarwalla, Anjali, et al.
Publicado: (2022)

Clinical presentations of hypertrophic cardiomyopathy and implications for therapy
por: Díez-López, Carles, et al.
Publicado: (2018)

Erratum: Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies
por: Frontiers Production Office,
Publicado: (2022)

A Contraction Stress Model of Hypertrophic Cardiomyopathy due to Sarcomere Mutations
por: Cohn, Rachel, et al.
Publicado: (2018)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1f7o0tjt6kji0kr9jvqcsav7dn